| 1. | Tissue type plasminogen activator
组织型纤溶酶原激活因子 |
| 2. | Experimental study of intracerebral transplantation of neural stem cells for treating parkinson ' disease
表皮细胞中钙离子调节组织型纤溶酶原激活剂表达的机制 |
| 3. | Effect of mifepristone on production of pl asminogen activators and progesterone in rat reproductive system
米非司酮对大鼠黄体和子宫内膜纤溶酶原激活因子的调节作用 |
| 4. | Construction of plasminogen activator and its expressive activity in human umbilical vein endothelial cell
组织型纤溶酶原激活因子构建及其在人脐静脉内皮细胞的表达活性 |
| 5. | Zhou hm , and liu yx ( 1997 ) : localization of tpa and pai - 1 in rat testes . chinese science bulletin . 42 : 588 - 591
周红明、刘以训( 1996 ) :组织型纤溶酶原激活因子及抑制因子的信使核糖核酸在大鼠睾丸中的定位。科学通报41 ： 455 458 。 |
| 6. | Zhou hm , zhang t and liu yx ( 1997 ) : localisation of lh receptor in rat epidydimis . chinese science bulletin 42 : 121 - 125
周红明、刘以训( 1996 ) :组织型纤溶酶原激活因子及抑制因子的信使核糖核酸在大鼠睾丸中的定位。科学通报41 ： 455 458 。 |
| 7. | Relationship between serum angiotension - converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with myocardial infarction
心肌梗死患者血清血管紧张素转换酶与血浆纤溶酶原激活剂抑制物1的活性及其相关性 |
| 8. | The relativity of the activity change of tissue - type plasminogen activator and type 1 plasminogen activator inhibitor in patients with cerebral infarction and defect of nerve function
脑梗死患者血浆组织型纤溶酶原激活物和纤溶酶原激活物抑制物活性的变化与神经功能缺损的相关性 |
| 9. | Tissue - type plasminogn activator ( t - pa ) is a kind of high efficient and specific thrombolytic medicine and is used widely to cure blood vessel embolism diseases . at present , t - pa has been expressed in e . coli
组织型纤溶酶原激活剂( tissue - typeplasminogenactivator , t - pa )是一种高效特异的溶血栓药物，被广泛地应用于血管栓塞性疾病的治疗。 |
| 10. | Angiostatin ( as ) is a kind of polypeptide identified as a product of plasminogen cleavaged by protease . it blocks neovascularization by directly inhibiting endothelial cell proliferation and migration
血管抑素( angiostatin ， as )是血浆纤溶酶原( plasminogen ， plg )经蛋白水解酶降解生成的多肽片段，是直接作用于血管内皮细胞的血管生成抑制剂。 |
